


下載本文檔
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認(rèn)領(lǐng)
文檔簡介
1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEEndoxifen hydrochlorideCat. No.: HY-18719BCAS No.: 1197194-41-4分式: CHClNO分量: 409.95作靶點: Estrogen Receptor/ERR作通路: Others儲存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實驗 DMSO : 35 mg/mL (85.38 mM)*
2、means soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制備儲備液1 mM 2.4393 mL 12.1966 mL 24.3932 mL5 mM 0.4879 mL 2.4393 mL 4.8786 mL10 mM 0.2439 mL 1.2197 mL 2.4393 mL請根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲備液,并請注意儲備液的保存式和期限。BIOLOGICAL ACTIVITY物活性 Endoxifen hydrochlorideTamoxifen 的活性代謝物,有效的雌
3、激素受體 (estrogen receptor) 拮抗劑。IC50 & Target Estrogen receptor 1體外研究Endoxifen blocks ER-alpha transcriptional activity and inhibits estrogen-induced breast cancer cellproliferation. These studies reveal that Endoxifen concentrations between 10 and 1000 nM enhance ER1/2 Master of Small Molecules 您邊的抑制劑
4、師www.MedChemEprotein degradation. Lower concentrations of Endoxifen (1 nM) do not affect ER protein levels 1.體內(nèi)研究 GLAST:Cre(ERT);ROSA26loxP/loxP mice are injected intraventricularly with 5 L 5 mM Endoxifen, and miceinjected with 4 L Adeno-Cre virus 109 plaque-forming units (pfu) serve as positive co
5、ntrol. At 7-10 daysafter ICV injection, mice are sacrificed and the SVZ dissected to isolate and derive stem and progenitor cells.These stem/progenitor cells are then cultured in permissive medium to form neurospheres and assayed forrecombination. In our unpassaged preparations is found derived from
6、 Endoxifen-injectedGLAST:CreERT2;ROSA26loxP/loxP mice that 1.9% of neurospheres show recombination, compared to ahigher rate of 4.3% of neurospheres in Adeno-Cre-recombined ROSA26loxP/loxP mice 2.PROTOCOLCell Assay 1 MCF7 and Ishikawa cells are grown in 10% triple charcoal-stripped serum-containing
7、medium for 3 d. Thecells are then plated at a density of 2,000 cells per well in 96-well tissue culture plates and treated asindicated every 48 h. Cell proliferation assays are conducted 8 days after the first treatment using a CellTiter-Glo Luminescent Cell Viability kit 1.MCE has not independently
8、 confirmed the accuracy of these methods. They are for reference only.Animal Mice 2Administration 2 GLAST:CreERT2 mice are used. Tamoxifen is injected as active metabolite 4-hydroxytamoxifen (4-OH-TAM), or 4-hydroxy-N-desmethyltamoxifen (Endoxifen). 4-OH-TAM is dissolved at 1 mM concentration in 2%e
9、thanol/PBS and 5 L injected into the ventricles. Endoxifen has not been used before for the induction of theERT2 system. Endoxifen hydrochloride hydrate has a recommended solubility of over 10 mg/mL (25 mM) in100% DMSO, corresponding to a maximum concentration of 25 mM or a dose of 125 nmol in a 5 L
10、 volume.At this concentration, a proportion of mice developed neurological signs suggestive of neurotoxicity.Subsequently, concentrations of 2.5, 5, 10, 12.5 and 25 mM, dissolved in 10, 20, 40, 50 and 100% DMSO,respectively, corresponding to a drug dose of 12.5, 25, 50, 62.5 and 125 nmol are used. F
11、or testing DMSOtoxicity, groups of three mice are injected with 5 uL PBS, 50% DMSO in PBS or 100% DMSO in PBS. Miceare culled 9 days after injection and coronally sectioned brains are stained for cleaved caspase 3, GFAP andIba1.MCE has not independently confirmed the accuracy of these methods. They
12、are for reference only.REFERENCES1. Wu X, et al. The tamoxifen metabolite, Endoxifen, is a potent antiestrogen that targets estrogen receptor alpha fordegradation in breastcancer cells. Cancer Res. 2009 Mar 1;69(5):1722-7.2. Benedykcinska A, et al.Generation of brain tumours in mice by Cre-mediated recombination of neural progenitors in situ with thetamoxifen metabolite Endoxifen. Dis Model Mech. 2016 Feb;9(2):211-20.McePdfHeightCaut
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 市政疏水管施工方案
- 公路平交施工方案
- 廠房石漆施工方案
- 河道駁坎施工方案
- 2025年度標(biāo)準(zhǔn)勞動關(guān)系解除與離職員工再就業(yè)服務(wù)協(xié)議
- 二零二五年度山場租賃承包與旅游開發(fā)協(xié)議
- 二零二五年度互聯(lián)網(wǎng)農(nóng)業(yè)合作入股協(xié)議
- 2025年度集體勞動合同到期續(xù)簽?zāi)0鍏f(xié)議
- 二零二五年度環(huán)境保護合作協(xié)議簽訂與審批流程
- 2025年度門面房租賃與商業(yè)形象設(shè)計合同
- 2024-2025學(xué)年廣州市高二語文上學(xué)期期末考試卷附答案解析
- 課題申報參考:中外文藝交流互鑒研究
- 少年商學(xué)院《DeepSeek中小學(xué)生使用手冊》
- 2025年山東鋁業(yè)職業(yè)學(xué)院高職單招職業(yè)技能測試近5年??及鎱⒖碱}庫含答案解析
- 2025年上半年天津中煤進出口限公司招聘電力及新能源專業(yè)人才易考易錯模擬試題(共500題)試卷后附參考答案
- 2024年教育公共基礎(chǔ)知識筆記
- 燃?xì)夤艿拦こ淌┕そM織設(shè)計方案
- 《銷售合同執(zhí)行》課件
- 深夜地鐵7號線施工方案
- 山東2024年山東經(jīng)貿(mào)職業(yè)學(xué)院第二批招聘102人歷年參考題庫(頻考版)含答案解析
- 宮腔球囊止血護理常規(guī)
評論
0/150
提交評論